March 28, 2013 — St. Jude Medical announced publication of results from its landmark RESPECT clinical trial in The New ...
Structural Heart Occluders
This channel includes news and new technology innovations about structural heart occluders. These include information of surgical repair and transcatheter closure of PFO, VSD, ASD and LAA. Devices include the Amplatzer and the Gore Helex
February 13, 2013 — St. Jude Medical has issued a Class I recall for its Amplatzer TorqVue FX Delivery System used in ...
This short cine loop shows a 3-D/4-D transesophegeal echo (TEE) view of a transcatheter Amplatzer closure device used to ...
The PC Trial data presented at TCT 2012 looked at transcather PFO closure vs. medical therapy in preventing cryptogenic ...
November 8, 2012 — A clinical trial indicates that using an investigational medical device to close a PFO, or “hole in ...
Positive results from the RESPECT Trial of transcatheter patent foramen ovale (PFO) closure vs. standard medical therapy ...
November 2, 2012 – A clinical trial that compared catheter-based PFO closure using an investigational device found that ...
October 30, 2012 — W. L. Gore & Associates responded to initial results reported in St. Jude Medical Inc.’s RESPECT ...
October 22, 2012 — W. L. Gore & Associates announced that the U.S. Food and Drug Administration (FDA) has approved the ...
October 19, 2012 — The 24th Transcatheter Cardiovascular Therapeutics (TCT) conference, sponsored by the Cardiovascular ...
October 4, 2012 — Researchers at the University of Maryland School of Medicine, who are exploring novel ways to treat ...
June 18, 2012 — St. Jude Medical Inc. announced it has received U.S. Food and Drug Administration (FDA) clearance and ...
May 31, 2012 — Occlutech GmbH, a European developer of minimally invasive implants for the treatment of structural heart ...
Methodist DeBakey Heart and Vascular Center in Houston, Tex., has leveraged new imaging and interventional technologies ...
April 24, 2012 - SeptRx, an emerging medical device company that has developed the SeptRx Intrapocket PFO Occluder (IPO) ...